No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Novel Coronavirus (COVID-19) : Coronavirus : The explosive rise in cases of coronavirus infection is of concern worldwide. Stay up-to-date here.

Thus, it may be not applicable in COVID-19 because the COVID-19 is a contagious disease and relatively irrelevant to a genetic disorder. Up to date, there is still a lack of clinical and laboratory ...